market position

Game-Changing Respiratory Breakthrough: GSK’s $14bn Aiolos Bio Acquisition!

📢 GSK breathes new life into its respiratory pipeline with $1.4bn Aiolos Bio acquisition, reinforcing commitment to patients worldwide. 😷💊🌍